Estrogen Deficiency: In Search of Symptom Control and Sexuality
Open Access
- 5 July 2000
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 92 (13) , 1028-1029
Abstract
Menopausal symptoms can be very prominent problems in women as they approach the age of 50 years and beyond. For at least three reasons, such problems are exacerbated in patients who have had breast cancer. First, cytotoxic chemotherapy in premenopausal women can cause an abrupt menopause, with marked symptoms. Second, the most commonly used antineoplastic drug in the world, tamoxifen, causes, as its most prominent toxic effect, hot flashes. Third, estrogen therapy, the most widely used treatment of women with menopausal symptoms, is often not used in patients with a history of breast cancer because of concerns about what estrogen might do regarding breast cancer.Keywords
This publication has 9 references indexed in Scilit:
- Managing Menopausal Symptoms in Breast Cancer Survivors: Results of a Randomized Controlled TrialJNCI: Journal of the National Cancer Institute, 2000
- Oral Clonidine in Postmenopausal Patients with Breast Cancer Experiencing Tamoxifen-Induced Hot Flashes: A University of Rochester Cancer Center Community Clinical Oncology Program StudyAnnals of Internal Medicine, 2000
- Evaluation of Soy Phytoestrogens for the Treatment of Hot Flashes in Breast Cancer Survivors: A North Central Cancer Treatment Group TrialJournal of Clinical Oncology, 2000
- A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil®) in controlling hot flashes in breast cancer survivorsAnnals of Oncology, 2000
- PILOT EVALUATION OF VENLAFAXINE FOR THE TREATMENT OF HOT FLASHES IN MEN UNDERGOING ANDROGEN ABLATION THERAPY FOR PROSTATE CANCERJournal of Urology, 1999
- Estrogen Replacement Therapy After Localized Breast Cancer: Clinical Outcome of 319 Women Followed ProspectivelyJournal of Clinical Oncology, 1999
- Prospective evaluation of vitamin E for hot flashes in breast cancer survivors.Journal of Clinical Oncology, 1998
- Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer.Journal of Clinical Oncology, 1997
- A Case-Control Study of Combined Continuous Estrogen???Progestin Replacement Therapy among Women with a Personal History of Breast CancerMenopause, 1995